The AHA Sept. 9 released a report highlighting how hospitals’ arrangements with community and specialty pharmacies improve access to care for underserved patients.

“The accessibility of community pharmacies presents a convenient, familiar, and dependable source of care,” the report notes. “This is especially true for those living in rural communities or who lack easy access to transportation.”

The report includes a number of data points on how 340B community and specialty pharmacies are located in counties that are experiencing issues that affect individuals’ health, including lack of insurance, food insecurity, high unemployment and severe housing problems.

“Importantly, these arrangements allow hospitals to better fulfill their 340B mission — to stretch scarce resources and expand access to care for more patients,” the report notes. “Collectively these data demonstrate the need for Congress to continue its strong bipartisan support of the program and reject efforts by big drug companies to undermine the program and the innumerable benefits it affords patients across the country.”
 

Headline
The AHA drafted and filed an amicus brief June 17 in the 5th U.S. Circuit Court of Appeals in a case regarding Medicaid financing and provider taxes filed by…
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
The AHA May 27 filed an amicus brief in the 7th U.S. Circuit Court of Appeals supporting the dismissal of an online tracking lawsuit against a member hospital…
Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…
Headline
The AHA today urged Eli Lilly to abandon its 340B Drug Pricing Program claims-data policy and work with the AHA to develop a functional third-party…